{"parse":{"title":"Blood substitute","pageid":415016,"revid":858141294,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">For the rugby union and rugby league term, see <a href=\"/wiki/Blood_replacement\" title=\"Blood replacement\">blood replacement</a>.</div>\n<p>A <b>blood substitute</b> (also called <b>artificial blood</b> or <b>blood surrogate</b>) is a substance used to mimic and fulfill some functions of <a href=\"/wiki/Biology\" title=\"Biology\">biological</a> <a href=\"/wiki/Blood\" title=\"Blood\">blood</a>. It aims to provide an alternative to <a href=\"/wiki/Blood_transfusion\" title=\"Blood transfusion\">blood transfusion</a>, which is transferring blood or <a href=\"/wiki/Blood-based_product\" class=\"mw-redirect\" title=\"Blood-based product\">blood-based products</a> from one person into another. Thus far, there are no well-accepted <i>oxygen-carrying</i> blood substitutes, which is the typical objective of a <a href=\"/wiki/Red_blood_cell\" title=\"Red blood cell\">red blood cell</a> transfusion; however, there are widely available non-blood <a href=\"/wiki/Volume_expander\" title=\"Volume expander\">volume expanders</a> for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of <a href=\"/wiki/Jehovah%27s_Witnesses\" title=\"Jehovah&#39;s Witnesses\">Jehovah's Witnesses</a> and others who have religious objections to receiving transfused blood.\n</p><p>The main categories of 'oxygen-carrying' blood substitutes being pursued are hemoglobin-based oxygen carriers (HBOC) and <a href=\"/wiki/Perfluorocarbon\" class=\"mw-redirect\" title=\"Perfluorocarbon\">perfluorocarbon</a>-based oxygen carriers (PFBOC).<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> Oxygen therapeutics are in clinical trials in the <a href=\"/wiki/United_States\" title=\"United States\">U.S.</a> and <a href=\"/wiki/Europe\" title=\"Europe\">Europe</a>, and <a href=\"/wiki/Biopure\" title=\"Biopure\">Hemopure</a> is available in <a href=\"/wiki/South_Africa\" title=\"South Africa\">South Africa</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Approaches\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Approaches</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Perfluorocarbon_based\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Perfluorocarbon based</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Haemoglobin_based\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Haemoglobin based</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Stem_cells\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Stem cells</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>After <a href=\"/wiki/William_Harvey\" title=\"William Harvey\">William Harvey</a> discovered blood pathways in 1616, many people tried to use fluids such as beer, urine, milk, and non-human animal blood as blood substitute.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> <a href=\"/wiki/Sir_Christopher_Wren\" class=\"mw-redirect\" title=\"Sir Christopher Wren\">Sir Christopher Wren</a> (17th century) suggested wine and opium as blood substitute.<sup id=\"cite_ref-pmid11834811_3-0\" class=\"reference\"><a href=\"#cite_note-pmid11834811-3\">&#91;3&#93;</a></sup>\n</p><p>At the beginning of the 20th century, the development of modern transfusion medicine initiated through the work of Landsteiner and co-authors opened the possibility to understanding the general principle of blood group serology.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>  Simultaneously, significant progress was made in the fields of heart and circulation physiology as well as in the understanding of the mechanism of oxygen transport and tissue oxygenation.<sup id=\"cite_ref-pmid6296890_5-0\" class=\"reference\"><a href=\"#cite_note-pmid6296890-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-pmid10749843_6-0\" class=\"reference\"><a href=\"#cite_note-pmid10749843-6\">&#91;6&#93;</a></sup>\n</p><p>Restrictions in applied transfusion medicine, especially in disaster situations such as World War Two, laid the grounds for accelerated research in the field of blood substitutes.<sup id=\"cite_ref-pmid12559026_7-0\" class=\"reference\"><a href=\"#cite_note-pmid12559026-7\">&#91;7&#93;</a></sup> Early attempts and optimism in developing blood substitutes were very quickly confronted with significant side effects, which could not be promptly eliminated due to the level of knowledge and technology available at that time. The <a href=\"/wiki/HIV#Discovery\" title=\"HIV\">emergence of HIV</a> in the 1980s renewed impetus for development of infection-safe blood substitutes.<sup id=\"cite_ref-pmid11834811_3-1\" class=\"reference\"><a href=\"#cite_note-pmid11834811-3\">&#91;3&#93;</a></sup> Public concern about the safety of the blood supply was raised further by <a href=\"/wiki/Mad_cow_disease\" class=\"mw-redirect\" title=\"Mad cow disease\">mad cow disease</a>.<sup id=\"cite_ref-pmid11834811_3-2\" class=\"reference\"><a href=\"#cite_note-pmid11834811-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid9971869_8-0\" class=\"reference\"><a href=\"#cite_note-pmid9971869-8\">&#91;8&#93;</a></sup> The continuous decline of blood donation combined with the increased demand for blood transfusion (increased ageing of population, increased incidence of invasive diagnostic, chemotherapy and extensive surgical interventions, terror attacks, international military conflicts) and positive estimation of investors in biotechnology branch made for a positive environment for further development of blood substitutes.<sup id=\"cite_ref-pmid9971869_8-1\" class=\"reference\"><a href=\"#cite_note-pmid9971869-8\">&#91;8&#93;</a></sup>\n</p><p>Efforts to develop blood substitutes have been driven by a desire to replace <a href=\"/wiki/Blood_transfusion\" title=\"Blood transfusion\">blood transfusion</a> in emergency situations, in places where infectious disease is endemic and the risk of <a href=\"/wiki/Contaminated_haemophilia_blood_products\" title=\"Contaminated haemophilia blood products\">contaminated blood products</a> is high, where refrigeration to preserve blood may be lacking, and where it might not be possible or convenient to find <a href=\"/wiki/Blood_type\" title=\"Blood type\">blood type</a> matches.<sup id=\"cite_ref-Alayash2017_9-0\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Approaches\">Approaches</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=2\" title=\"Edit section: Approaches\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Efforts having focused on molecules that can carry <a href=\"/wiki/Oxygen\" title=\"Oxygen\">oxygen</a>, and most work has focused on recombinant <a href=\"/wiki/Haemoglobin\" class=\"mw-redirect\" title=\"Haemoglobin\">haemoglobin</a>, which normally carries oxygen, and <a href=\"/wiki/Perfluorocarbons\" class=\"mw-redirect\" title=\"Perfluorocarbons\">perfluorocarbons</a> (PFC), chemical compounds which can carry and release oxygen.<sup id=\"cite_ref-Alayash2017_9-1\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-pmid10695091_10-0\" class=\"reference\"><a href=\"#cite_note-pmid10695091-10\">&#91;10&#93;</a></sup>\n</p><p>The first approved oxygen-carrying blood substitute was a perfluorocarbon-based product called <a href=\"/wiki/Fluosol\" class=\"mw-redirect\" title=\"Fluosol\">Fluosol</a>-DA-20, manufactured by <a href=\"/wiki/Green_Cross_(Japan)\" title=\"Green Cross (Japan)\">Green Cross</a> of Japan. It was approved by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) in 1989. Because of limited success, complexity of use and side effects, it was withdrawn in 1994. However, Fluosol-DA remains the only oxygen therapeutic ever fully approved by the FDA.  As of 2017 no haemoglobin-based product had been approved.<sup id=\"cite_ref-Alayash2017_9-2\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Perfluorocarbon_based\">Perfluorocarbon based</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=3\" title=\"Edit section: Perfluorocarbon based\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Blood_substitute&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(February 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>Perfluorochemicals are not <a href=\"/wiki/Water_soluble\" class=\"mw-redirect\" title=\"Water soluble\">water soluble</a>, so will not mix with blood, therefore <a href=\"/wiki/Emulsion\" title=\"Emulsion\">emulsions</a> must be made by dispersing small drops of PFC in <a href=\"/wiki/Water\" title=\"Water\">water</a>. This liquid is then mixed with <a href=\"/wiki/Antibiotics\" class=\"mw-redirect\" title=\"Antibiotics\">antibiotics</a>, <a href=\"/wiki/Vitamin\" title=\"Vitamin\">vitamins</a>, <a href=\"/wiki/Nutrient\" title=\"Nutrient\">nutrients</a> and <a href=\"/wiki/Salt_(chemistry)\" title=\"Salt (chemistry)\">salts</a>, producing a mixture that contains about 80 different components, and performs many of the vital functions of natural blood. PFC particles are about <span class=\"sfrac nowrap\" style=\"display:inline-block; vertical-align:-0.5em; font-size:85%; text-align:center;\"><span style=\"display:block; line-height:1em; margin:0 0.1em;\">1</span><span class=\"visualhide\">/</span><span style=\"display:block; line-height:1em; margin:0 0.1em; border-top:1px solid;\">40</span></span>th the size of the diameter of a <a href=\"/wiki/Red_blood_cell\" title=\"Red blood cell\">red blood cell</a> (RBC). This small size can enable PFC particles to traverse <a href=\"/wiki/Capillaries\" class=\"mw-redirect\" title=\"Capillaries\">capillaries</a> through which no RBCs are flowing. In theory this can benefit damaged, blood-starved <a href=\"/wiki/Biological_tissue\" class=\"mw-redirect\" title=\"Biological tissue\">tissue</a>, which conventional red cells cannot reach. PFC solutions can carry oxygen so well that <a href=\"/wiki/Mammal\" title=\"Mammal\">mammals</a>, including <a href=\"/wiki/Human\" title=\"Human\">humans</a>, can survive breathing liquid PFC solution, called <a href=\"/wiki/Liquid_breathing\" title=\"Liquid breathing\">liquid breathing</a>.\n</p><p>Perfluorocarbon-based blood substitutes are completely man-made; this provides advantages over blood substitutes that rely on modified haemoglobin, such as unlimited manufacturing capabilities, ability to be heat-sterilized, and PFCs' efficient oxygen delivery and carbon dioxide removal. PFCs in solution act as an intravascular oxygen carrier to temporarily augment oxygen delivery to tissues. PFCs are removed from the bloodstream within 48 hours by the body's normal clearance procedure for particles in the blood \u2013 exhalation. PFC particles in solution can carry several times more oxygen per cubic centimeter (cc) than blood, while being 40 to 50 times smaller than haemoglobin.\n</p><p>Fluosol was made mostly of <a href=\"/wiki/Perfluorodecalin\" title=\"Perfluorodecalin\">perfluorodecalin</a> or <a href=\"/wiki/Perfluorotributylamine\" title=\"Perfluorotributylamine\">perfluorotributylamine</a> suspended in an <a href=\"/wiki/Albumin\" title=\"Albumin\">albumin</a> emulsion. It was developed in <a href=\"/wiki/Japan\" title=\"Japan\">Japan</a> and first tested in the <a href=\"/wiki/United_States\" title=\"United States\">United States</a> in November 1979. In order to \"load\" sufficient amounts of oxygen into it, people who had been given it had to breathe pure oxygen by mask or in a <a href=\"/wiki/Hyperbaric_chamber\" class=\"mw-redirect\" title=\"Hyperbaric chamber\">hyperbaric chamber</a>.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> It was approved by the FDA in 1989,<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> and was approved in eight other countries.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (December 2017)\">citation needed</span></a></i>&#93;</sup> Its use was associated with a reduction in ischemic complications and with an increase in pulmonary edema and congestive heart failure.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>  Due to difficulty with the emulsion storage of Fluosol use (frozen storage and rewarming), its popularity declined and its production ended in 1994.<sup id=\"cite_ref-Alayash2017_9-3\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p>\n<table class=\"sortable wikitable\">\n\n<tbody><tr>\n<th>Name\n</th>\n<th>Sponsor\n</th>\n<th>Description\n</th></tr>\n<tr>\n<td><a href=\"/wiki/Oxycyte\" title=\"Oxycyte\">Oxycyte</a>\n</td>\n<td>Oxygen Biotherapeutics\n</td>\n<td>Tested in a Phase II-b Trials in the United States. Targeted as an <a href=\"/wiki/Oxygen_therapeutic\" class=\"mw-redirect\" title=\"Oxygen therapeutic\">oxygen therapeutic</a> rather than a blood substitute, with successful small-scale open label human trials treating <a href=\"/wiki/Traumatic_brain_injury\" title=\"Traumatic brain injury\">traumatic brain injury</a> at Virginia Commonwealth University.<sup id=\"cite_ref-Yoffee08_14-0\" class=\"reference\"><a href=\"#cite_note-Yoffee08-14\">&#91;14&#93;</a></sup> The trial was later terminated.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</td></tr>\n<tr>\n<td>PHER-<span class=\"chemf nowrap\">O<span style=\"display:inline-block;margin-bottom:-0.3em;vertical-align:-0.4em;line-height:1em;font-size:80%;text-align:left\"><sup style=\"font-size:inherit;line-height:inherit;vertical-align:baseline\"></sup><br /><sub style=\"font-size:inherit;line-height:inherit;vertical-align:baseline\">2</sub></span></span>\n</td>\n<td>Sanguine Corp\n</td>\n<td>In research\n</td></tr>\n<tr>\n<td>Perftoran\n</td>\n<td>Russia\n</td>\n<td>Contains <a href=\"/wiki/Perfluorodecalin\" title=\"Perfluorodecalin\">perfluorodecalin</a> and perfluoro-N-(4-methylcyclohexyl)-piperidine along with a <a href=\"/wiki/Surfactant\" title=\"Surfactant\">surfactant</a>, Proxanol-268.  It was developed in Russia and as of 2005 was marketed there.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>\n</td></tr>\n<tr>\n<td>NVX-108\n</td>\n<td>NuvOx Pharma\n</td>\n<td>In a Phase Ib/II clinical trial where it raises tumor oxygen levels prior to radiation therapy in order to radiosensitize them.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</td></tr></tbody></table>\n<p>Oxygent was a second-generation, <a href=\"/wiki/Lecithin\" title=\"Lecithin\">lecithin</a>-stabilized <a href=\"/wiki/Emulsion\" title=\"Emulsion\">emulsion</a> of a PFC that was under development by Alliance Pharmaceuticals.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>   In 2002 a Phase III study was halted early due an increase in incidences of strokes in the study arm.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Haemoglobin_based\">Haemoglobin based</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=4\" title=\"Edit section: Haemoglobin based\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Haemoglobin\" class=\"mw-redirect\" title=\"Haemoglobin\">Haemoglobin</a> is the main component of red blood cells, comprising about 33% of the cell mass. Haemoglobin-based products are called haemoglobin-based oxygen carriers (HBOCs).\n</p><p>Unmodified cell-free haemoglobin is not useful as a blood substitute because its oxygen affinity is too high for effective tissue oxygenation, the half-life within the intravascular space that is too short to be clinically useful, it has a tendency to undergo dissociation in dimers with resultant kidney damage and toxicity, and because free haemoglobin tends to take up nitric oxide, causing vasoconstriction.<sup id=\"cite_ref-pmid11834811_3-3\" class=\"reference\"><a href=\"#cite_note-pmid11834811-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-NatansonJAMA2008_24-0\" class=\"reference\"><a href=\"#cite_note-NatansonJAMA2008-24\">&#91;24&#93;</a></sup>\n</p><p>Efforts to overcome this toxicity have included making <a href=\"/wiki/Genetically_engineered\" class=\"mw-redirect\" title=\"Genetically engineered\">genetically engineered</a> versions, <a href=\"/wiki/Cross-link\" title=\"Cross-link\">cross-linking</a>, <a href=\"/wiki/Polymerization\" title=\"Polymerization\">polymerization</a>, and encapsulation.<sup id=\"cite_ref-Alayash2017_9-4\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p><p>HemAssist, a diaspirin cross-linked haemoglobin (DCLHb) was developed by <a href=\"/wiki/Baxter_Healthcare\" class=\"mw-redirect\" title=\"Baxter Healthcare\">Baxter Healthcare</a>; it was the most widely studied of the haemoglobin-based blood substitutes, used in more than a dozen animal and clinical studies.<sup id=\"cite_ref-pmid12559026_7-1\" class=\"reference\"><a href=\"#cite_note-pmid12559026-7\">&#91;7&#93;</a></sup>   It reached Phase III clinical trials, in which failed due to increased mortality in the trial arm, mostly due to severe vasoconstriction complications.<sup id=\"cite_ref-Alayash2017_9-5\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-pmid12559026_7-2\" class=\"reference\"><a href=\"#cite_note-pmid12559026-7\">&#91;7&#93;</a></sup>   The results were published in 1999.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p><p>Hemolink (Hemosol, Inc., Mississauga, Canada) was a haemoglobin solution that contained cross-linked an o-rafinose polymerised human haemoglobin,<sup id=\"cite_ref-Alayash2017_9-6\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup> which struggled after Phase II trials were halted in 2003 on safety concerns.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>  It declared bankruptcy in 2005.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p><p>Hemopure was developed by Biopure Corp and was a chemically stabilized, cross-linked bovine (cow) haemoglobin in a salt solution intended for human use; the company developed the same product under the trade name Oxyglobin for veterinary use in dogs.  Oxyglobin was approved in the US and Europe and was introduced to veterinary clinics and hospitals in March 1998. Hemopure was approved in South Africa but that approval was revoked and Biopure filed for bankruptcy protection in 2009.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> Its assets were subsequently purchased by OPK Biotech.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (December 2017)\">citation needed</span></a></i>&#93;</sup>\n</p><p>PolyHeme was developed over 20 years by <a href=\"/wiki/Northfield_Laboratories\" title=\"Northfield Laboratories\">Northfield Laboratories</a> and began as a military project following the Vietnam War. It is human haemoglobin, extracted from red blood cells, then polymerized, then incorporated into an electrolyte solution. In April 2009, the FDA rejected Northfield's <a href=\"/wiki/Biologic_License_Application\" class=\"mw-redirect\" title=\"Biologic License Application\">Biologic License Application</a><sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> and in June 2009, Northfield filed for bankruptcy.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\n</p><p>Dextran-Haemoglobin was developed by Dextro-Sang Corp as a veterinary product, and was a conjugate of the polymer dextran with human haemoglobin.\n</p><p>Hemotech was developed by HemoBiotech and was a chemically modified haemoglobin.\n</p><p>Somatogen developed a genetically engineered and crosslinked tetramer it called Optro. It failed in a phase II trial that was published in 2014 and development was halted.<sup id=\"cite_ref-Alayash2017_9-7\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p><p>A pyridoxylated Hb conjugated with <a href=\"/wiki/Polyoxyethylene\" class=\"mw-redirect\" title=\"Polyoxyethylene\">polyoxyethylene</a> was created by scientists at Ajinomoto and eventually developed by Apex Biosciences, a subsidiary of Curacyte AG; it was called \"PHP\" and failed in a Phase III trial published in 2014, due to increased mortality in the control arm,<sup id=\"cite_ref-Alayash2017_9-8\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> which led to Curacyte shutting down.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p>Similarly, Hemospan was developed by Sangart, and was a <a href=\"/wiki/PEGylation\" title=\"PEGylation\">pegylated</a> haemoglobin provided in a powdered form. While early trials were promising Sangart ran out of funding and closed down.<sup id=\"cite_ref-Alayash2017_9-9\" class=\"reference\"><a href=\"#cite_note-Alayash2017-9\">&#91;9&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Stem_cells\">Stem cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=5\" title=\"Edit section: Stem cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Stem_cell\" title=\"Stem cell\">Stem cells</a> offer a possible means of producing transfusable blood. A study performed by Giarratana et al.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> describes a large-scale ex-vivo production of mature human blood cells using <a href=\"/wiki/Hematopoietic_stem_cell\" title=\"Hematopoietic stem cell\">hematopoietic stem cells</a>. The cultured cells possessed the same haemoglobin content and morphology as native red blood cells. The authors contend that the cells had a near-normal lifespan, when compared to natural red blood cells.\n</p><p>Scientists from the experimental arm of the <a href=\"/wiki/United_States_Department_of_Defense\" title=\"United States Department of Defense\">United States Department of Defense</a> began creating artificial blood for use in remote areas and transfuse blood to wounded soldiers more quickly in 2010.<sup id=\"cite_ref-Edwards_34-0\" class=\"reference\"><a href=\"#cite_note-Edwards-34\">&#91;34&#93;</a></sup> The blood is made from the <a href=\"/wiki/Hematopoietic\" class=\"mw-redirect\" title=\"Hematopoietic\">hematopoietic</a> stem cells removed from <a href=\"/wiki/Umbilical_cord\" title=\"Umbilical cord\">umbilical cord</a> between the mother and fetus of humans after birth using a method called blood pharming. Pharming has been used in the past on animals and plants to create medical substances in large quantities. Each cord can produce approximately 20 units of blood or three blood transfusions. The blood is being produced for the <a href=\"/wiki/Defense_Advanced_Research_Projects_Agency\" class=\"mw-redirect\" title=\"Defense Advanced Research Projects Agency\">Defense Advanced Research Projects Agency</a> by Arteriocyte. The <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> has examined and approved the safety of this blood from previously submitted O-negative blood. Using this particular artificial blood will reduce the costs per unit of blood from $5,000 to equal or less than $1,000.<sup id=\"cite_ref-Edwards_34-1\" class=\"reference\"><a href=\"#cite_note-Edwards-34\">&#91;34&#93;</a></sup> This blood will also serve as a blood donor to all <a href=\"/wiki/Blood_types\" class=\"mw-redirect\" title=\"Blood types\">blood types</a>. Pharmed blood may be used in human trials in 2013.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=6\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><i><a href=\"/wiki/Artificial_Cells,_Blood_Substitutes,_and_Biotechnology\" title=\"Artificial Cells, Blood Substitutes, and Biotechnology\">Artificial Cells, Blood Substitutes, and Biotechnology</a></i> (journal)</li>\n<li><a href=\"/wiki/Blood_transfusion\" title=\"Blood transfusion\">Blood transfusion</a></li>\n<li><a href=\"/wiki/Bloodless_surgery\" title=\"Bloodless surgery\">Bloodless surgery</a></li>\n<li><a href=\"/wiki/Theatrical_blood\" title=\"Theatrical blood\">Theatrical blood</a></li>\n<li><a href=\"/wiki/Blood_plasma_substitute_(disambiguation)\" class=\"mw-redirect mw-disambig\" title=\"Blood plasma substitute (disambiguation)\">Blood plasma substitute (disambiguation)</a></li>\n<li><a href=\"/wiki/Induced_stem_cells#Blood_stem_cells\" title=\"Induced stem cells\">Induced Blood stem cells</a></li>\n<li><a href=\"/wiki/Erythromer\" title=\"Erythromer\">Erythromer</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=7\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Henkel-Honke, T.; Oleck, M. (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160304185434/http://www.aana.com/newsandjournal/Documents/henkelhanke205-211.pdf\">\"Artificial oxygen carriers: A current review\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>AANA Journal</i>. <b>75</b> (3): 205\u2013211. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17591302\">17591302</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.aana.com/newsandjournal/Documents/henkelhanke205-211.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2016-03-04<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-02-09</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=AANA+Journal&amp;rft.atitle=Artificial+oxygen+carriers%3A+A+current+review&amp;rft.volume=75&amp;rft.issue=3&amp;rft.pages=205-211&amp;rft.date=2007&amp;rft_id=info%3Apmid%2F17591302&amp;rft.aulast=Henkel-Honke&amp;rft.aufirst=T.&amp;rft.au=Oleck%2C+M.&amp;rft_id=http%3A%2F%2Fwww.aana.com%2Fnewsandjournal%2FDocuments%2Fhenkelhanke205-211.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sarkar, S. (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2738310\">\"Artificial Blood\"</a>. <i>Indian Journal of Critical Care Medicine</i>. <b>12</b> (3): 140\u2013144. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4103/0972-5229.43685\">10.4103/0972-5229.43685</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2738310\">2738310</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19742251\">19742251</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+Journal+of+Critical+Care+Medicine&amp;rft.atitle=Artificial+Blood&amp;rft.volume=12&amp;rft.issue=3&amp;rft.pages=140-144&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2738310&amp;rft_id=info%3Apmid%2F19742251&amp;rft_id=info%3Adoi%2F10.4103%2F0972-5229.43685&amp;rft.aulast=Sarkar&amp;rft.aufirst=S.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2738310&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid11834811-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid11834811_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid11834811_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid11834811_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid11834811_3-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Squires JE (2002). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencemag.org/cgi/pmidlookup?view=long&amp;pmid=11834811\">\"Artificial blood\"</a>. <i><a href=\"/wiki/Science_(journal)\" title=\"Science (journal)\">Science</a></i>. <b>295</b> (5557): 1002\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1068443\">10.1126/science.1068443</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11834811\">11834811</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Artificial+blood&amp;rft.volume=295&amp;rft.issue=5557&amp;rft.pages=1002-5&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1068443&amp;rft_id=info%3Apmid%2F11834811&amp;rft.au=Squires+JE&amp;rft_id=http%3A%2F%2Fwww.sciencemag.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11834811&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Boulton, FE (December 2013). \"Blood transfusion; additional historical aspects. Part 1. The birth of transfusion immunology\". <i>Transfusion medicine (Oxford, England)</i>. <b>23</b> (6): 375\u201381. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/tme.12075\">10.1111/tme.12075</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24003949\">24003949</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transfusion+medicine+%28Oxford%2C+England%29&amp;rft.atitle=Blood+transfusion%3B+additional+historical+aspects.+Part+1.+The+birth+of+transfusion+immunology.&amp;rft.volume=23&amp;rft.issue=6&amp;rft.pages=375-81&amp;rft.date=2013-12&amp;rft_id=info%3Adoi%2F10.1111%2Ftme.12075&amp;rft_id=info%3Apmid%2F24003949&amp;rft.aulast=Boulton&amp;rft.aufirst=FE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid6296890-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid6296890_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Feigl, EO (January 1983). \"Coronary physiology\". <i>Physiological Reviews</i>. <b>63</b> (1): 1\u2013205. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1152/physrev.1983.63.1.1\">10.1152/physrev.1983.63.1.1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6296890\">6296890</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Physiological+Reviews&amp;rft.atitle=Coronary+physiology.&amp;rft.volume=63&amp;rft.issue=1&amp;rft.pages=1-205&amp;rft.date=1983-01&amp;rft_id=info%3Adoi%2F10.1152%2Fphysrev.1983.63.1.1&amp;rft_id=info%3Apmid%2F6296890&amp;rft.aulast=Feigl&amp;rft.aufirst=EO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10749843-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10749843_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lahiri, S (April 2000). \"Historical perspectives of cellular oxygen sensing and responses to hypoxia\". <i>Journal of Applied Physiology</i>. <b>88</b> (4): 1467\u201373. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1152/jappl.2000.88.4.1467\">10.1152/jappl.2000.88.4.1467</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10749843\">10749843</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Applied+Physiology&amp;rft.atitle=Historical+perspectives+of+cellular+oxygen+sensing+and+responses+to+hypoxia.&amp;rft.volume=88&amp;rft.issue=4&amp;rft.pages=1467-73&amp;rft.date=2000-04&amp;rft_id=info%3Adoi%2F10.1152%2Fjappl.2000.88.4.1467&amp;rft_id=info%3Apmid%2F10749843&amp;rft.aulast=Lahiri&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid12559026-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid12559026_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid12559026_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid12559026_7-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Reid TJ (2003). \"Hb-based oxygen carriers: are we there yet?\". <i><a href=\"/wiki/Transfusion_(journal)\" class=\"mw-redirect\" title=\"Transfusion (journal)\">Transfusion</a></i>. <b>43</b> (2): 280\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1046/j.1537-2995.2003.00314.x\">10.1046/j.1537-2995.2003.00314.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12559026\">12559026</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transfusion&amp;rft.atitle=Hb-based+oxygen+carriers%3A+are+we+there+yet%3F&amp;rft.volume=43&amp;rft.issue=2&amp;rft.pages=280-7&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1537-2995.2003.00314.x&amp;rft_id=info%3Apmid%2F12559026&amp;rft.au=Reid+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid9971869-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9971869_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9971869_8-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP (1999). \"Transfusion medicine. First of two parts--blood transfusion\". <i><a href=\"/wiki/N._Engl._J._Med.\" class=\"mw-redirect\" title=\"N. Engl. J. Med.\">N. Engl. J. Med.</a></i> <b>340</b> (6): 438\u201347. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM199902113400606\">10.1056/NEJM199902113400606</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9971869\">9971869</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Transfusion+medicine.+First+of+two+parts--blood+transfusion&amp;rft.volume=340&amp;rft.issue=6&amp;rft.pages=438-47&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199902113400606&amp;rft_id=info%3Apmid%2F9971869&amp;rft.aulast=Goodnough&amp;rft.aufirst=LT&amp;rft.au=Brecher%2C+ME&amp;rft.au=Kanter%2C+MH&amp;rft.au=AuBuchon%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Alayash2017-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Alayash2017_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Alayash2017_9-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alayash, AI (4 January 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5372714\">\"Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?\"</a>. <i>Biomolecules</i>. <b>7</b> (1). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/biom7010002\">10.3390/biom7010002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5372714\">5372714</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28054978\">28054978</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biomolecules&amp;rft.atitle=Hemoglobin-Based+Blood+Substitutes+and+the+Treatment+of+Sickle+Cell+Disease%3A+More+Harm+than+Help%3F&amp;rft.volume=7&amp;rft.issue=1&amp;rft.date=2017-01-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5372714&amp;rft_id=info%3Apmid%2F28054978&amp;rft_id=info%3Adoi%2F10.3390%2Fbiom7010002&amp;rft.aulast=Alayash&amp;rft.aufirst=AI&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5372714&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10695091-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10695091_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Remy B, Deby-Dupont G, Lamy M (1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://bmb.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=10695091\">\"Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions\"</a>. <i><a href=\"/wiki/Br._Med._Bull.\" class=\"mw-redirect\" title=\"Br. Med. Bull.\">Br. Med. Bull.</a></i> <b>55</b> (1): 277\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1258/0007142991902259\">10.1258/0007142991902259</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10695091\">10695091</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br.+Med.+Bull.&amp;rft.atitle=Red+blood+cell+substitutes%3A+fluorocarbon+emulsions+and+haemoglobin+solutions&amp;rft.volume=55&amp;rft.issue=1&amp;rft.pages=277-98&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1258%2F0007142991902259&amp;rft_id=info%3Apmid%2F10695091&amp;rft.aulast=Remy&amp;rft.aufirst=B&amp;rft.au=Deby-Dupont%2C+G&amp;rft.au=Lamy%2C+M&amp;rft_id=http%3A%2F%2Fbmb.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10695091&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\">Marieb, Elaine Nicpon. <u>Human Anatomy &amp; Physiology</u>. 4th ed. Menlo Park, California: Addison Wesley Longman, Inc. 1998. 650.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Bruno, S.; Ronda, L.; Faggiano, S.; Bettati, S.; Mozzarelli, A. (2010). \"Oxygen Delivery via Allosteric Effectors of Hemoglobin and Blood Substitutes\". <i>Burger's Medicinal Chemistry and Drug Discovery</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/0471266949.bmc048.pub2\">10.1002/0471266949.bmc048.pub2</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0471266949\" title=\"Special:BookSources/0471266949\">0471266949</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Oxygen+Delivery+via+Allosteric+Effectors+of+Hemoglobin+and+Blood+Substitutes&amp;rft.btitle=Burger%27s+Medicinal+Chemistry+and+Drug+Discovery&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1002%2F0471266949.bmc048.pub2&amp;rft.isbn=0471266949&amp;rft.aulast=Bruno&amp;rft.aufirst=S.&amp;rft.au=Ronda%2C+L.&amp;rft.au=Faggiano%2C+S.&amp;rft.au=Bettati%2C+S.&amp;rft.au=Mozzarelli%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wall, T. C.; Califf, R. M.; Blankenship, J.; Talley, J. D.; Tannenbaum, M.; Schwaiger, M.; Gacioch, G.; Cohen, M. D.; Sanz, M.; Leimberger, J. D. (1994). <a rel=\"nofollow\" class=\"external text\" href=\"http://circ.ahajournals.org/content/90/1/114.abstract\">\"Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group\"</a>. <i>Circulation</i>. <b>90</b> (1): 114\u2013120. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/01.CIR.90.1.114\">10.1161/01.CIR.90.1.114</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8025985\">8025985</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Intravenous+Fluosol+in+the+treatment+of+acute+myocardial+infarction.+Results+of+the+Thrombolysis+and+Angioplasty+in+Myocardial+Infarction+9+Trial.+TAMI+9+Research+Group&amp;rft.volume=90&amp;rft.issue=1&amp;rft.pages=114-120&amp;rft.date=1994&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.90.1.114&amp;rft_id=info%3Apmid%2F8025985&amp;rft.aulast=Wall&amp;rft.aufirst=T.+C.&amp;rft.au=Califf%2C+R.+M.&amp;rft.au=Blankenship%2C+J.&amp;rft.au=Talley%2C+J.+D.&amp;rft.au=Tannenbaum%2C+M.&amp;rft.au=Schwaiger%2C+M.&amp;rft.au=Gacioch%2C+G.&amp;rft.au=Cohen%2C+M.+D.&amp;rft.au=Sanz%2C+M.&amp;rft.au=Leimberger%2C+J.+D.&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcontent%2F90%2F1%2F114.abstract&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Yoffee08-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Yoffee08_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yoffee, Lynn (May 1, 2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.thefreelibrary.com/Oxycyte+is+on+track+as+oxygen+carrier,+not+as+&#39;faux&#39;+blood-a0204011942\">\"Oxycyte is on track as oxygen carrier, not as 'faux' blood\"</a>. <i>Cardiovascular Device &amp; Drugs</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-06-30</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cardiovascular+Device+%26+Drugs&amp;rft.atitle=Oxycyte+is+on+track+as+oxygen+carrier%2C+not+as+%27faux%27+blood.&amp;rft.date=2008-05-01&amp;rft.au=Yoffee%2C+Lynn&amp;rft_id=http%3A%2F%2Fwww.thefreelibrary.com%2FOxycyte%2Bis%2Bon%2Btrack%2Bas%2Boxygen%2Bcarrier%2C%2Bnot%2Bas%2B%27faux%27%2Bblood-a0204011942&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since April 2017\">dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT00908063\">\"Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI) (STOP-TBI)\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Safety+and+Tolerability+of+Oxycyte+in+Patients+With+Traumatic+Brain+Injury+%28TBI%29+%28STOP-TBI%29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00908063&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Maevsky, E; Ivanitsky, G; Bogdanova, L; Axenova, O; Karmen, N; Zhiburt, E; Senina, R; Pushkin, S; Maslennikov, I; Orlov, A; Marinicheva, I (2005). \"Clinical results of Perftoran application: present and future\". <i>Artificial cells, blood substitutes, and immobilization biotechnology</i>. <b>33</b> (1): 37\u201346. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15768564\">15768564</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&amp;rft.atitle=Clinical+results+of+Perftoran+application%3A+present+and+future.&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=37-46&amp;rft.date=2005&amp;rft_id=info%3Apmid%2F15768564&amp;rft.aulast=Maevsky&amp;rft.aufirst=E&amp;rft.au=Ivanitsky%2C+G&amp;rft.au=Bogdanova%2C+L&amp;rft.au=Axenova%2C+O&amp;rft.au=Karmen%2C+N&amp;rft.au=Zhiburt%2C+E&amp;rft.au=Senina%2C+R&amp;rft.au=Pushkin%2C+S&amp;rft.au=Maslennikov%2C+I&amp;rft.au=Orlov%2C+A&amp;rft.au=Marinicheva%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT02189109\">\"The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma (GBM)\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Effects+of+NVX-108+as+a+Radiation+Sensitizer+in+Glioblastoma+%28GBM%29&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02189109&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vorob\u2019ev, S. I. (2009-08-19). \"First- and second-generation perfluorocarbon emulsions\". <i>Pharmaceutical Chemistry Journal</i>. <b>43</b> (4): 209\u2013218. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11094-009-0268-1\">10.1007/s11094-009-0268-1</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0091-150X\">0091-150X</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmaceutical+Chemistry+Journal&amp;rft.atitle=First-+and+second-generation+perfluorocarbon+emulsions&amp;rft.volume=43&amp;rft.issue=4&amp;rft.pages=209-218&amp;rft.date=2009-08-19&amp;rft_id=info%3Adoi%2F10.1007%2Fs11094-009-0268-1&amp;rft.issn=0091-150X&amp;rft.aulast=Vorob%E2%80%99ev&amp;rft.aufirst=S.+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cohn, Claudia S.; Cushing, Melissa M. (2009-04-01). \"Oxygen Therapeutics: Perfluorocarbons and Blood Substitute Safety\". <i>Critical Care Clinics</i>. Hemoglobin-based Oxygen Carriers (HBOCs): The Future in Resuscitation?. <b>25</b> (2): 399\u2013414. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccc.2008.12.007\">10.1016/j.ccc.2008.12.007</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Care+Clinics&amp;rft.atitle=Oxygen+Therapeutics%3A+Perfluorocarbons+and+Blood+Substitute+Safety&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=399-414&amp;rft.date=2009-04-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccc.2008.12.007&amp;rft.aulast=Cohn&amp;rft.aufirst=Claudia+S.&amp;rft.au=Cushing%2C+Melissa+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cohn, Claudia S.; Cushing, Melissa M. (2009). \"Oxygen Therapeutics: Perfluorocarbons and Blood Substitute Safety\". <i>Critical Care Clinics</i>. <b>25</b> (2): 399\u2013414. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccc.2008.12.007\">10.1016/j.ccc.2008.12.007</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Care+Clinics&amp;rft.atitle=Oxygen+Therapeutics%3A+Perfluorocarbons+and+Blood+Substitute+Safety&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=399-414&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccc.2008.12.007&amp;rft.aulast=Cohn&amp;rft.aufirst=Claudia+S.&amp;rft.au=Cushing%2C+Melissa+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Niiler, Eric (2002-10-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/nbt/journal/v20/n10/full/nbt1002-962.html\">\"Setbacks for blood substitute companies\"</a>. <i>Nature Biotechnology</i>. <b>20</b> (10): 962\u2013963. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt1002-962\">10.1038/nbt1002-962</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1087-0156\">1087-0156</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Setbacks+for+blood+substitute+companies&amp;rft.volume=20&amp;rft.issue=10&amp;rft.pages=962-963&amp;rft.date=2002-10-01&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt1002-962&amp;rft.issn=1087-0156&amp;rft.aulast=Niiler&amp;rft.aufirst=Eric&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnbt%2Fjournal%2Fv20%2Fn10%2Ffull%2Fnbt1002-962.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Amberson, William; Jennings J.; Rhode C. (1949). <a rel=\"nofollow\" class=\"external text\" href=\"http://jap.physiology.org/content/1/7/469.long\">\"Clinical Experience with Hemoglobin-Saline Solutions\"</a>. <i>Journal of Applied Physiology</i>. <b>1</b> (7): 469\u2013489. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18104040\">18104040</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Applied+Physiology&amp;rft.atitle=Clinical+Experience+with+Hemoglobin-Saline+Solutions&amp;rft.volume=1&amp;rft.issue=7&amp;rft.pages=469-489&amp;rft.date=1949&amp;rft_id=info%3Apmid%2F18104040&amp;rft.aulast=Amberson&amp;rft.aufirst=William&amp;rft.au=Jennings+J.&amp;rft.au=Rhode+C.&amp;rft_id=http%3A%2F%2Fjap.physiology.org%2Fcontent%2F1%2F7%2F469.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jiin-Yu Chen; Michelle Scerbo; George Kramer (August 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2728196\">\"A Review of Blood Substitutes: Examining The History, Clinical Trial Results, and Ethics of Hemoglobin-Based Oxygen Carriers\"</a>. <i>Clinics (Sao Paulo)</i>. <b>64</b> (8): 803\u2013813. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1590/S1807-59322009000800016\">10.1590/S1807-59322009000800016</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2728196\">2728196</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19690667\">19690667</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinics+%28Sao+Paulo%29&amp;rft.atitle=A+Review+of+Blood+Substitutes%3A+Examining+The+History%2C+Clinical+Trial+Results%2C+and+Ethics+of+Hemoglobin-Based+Oxygen+Carriers&amp;rft.volume=64&amp;rft.issue=8&amp;rft.pages=803-813&amp;rft.date=2009-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2728196&amp;rft_id=info%3Apmid%2F19690667&amp;rft_id=info%3Adoi%2F10.1590%2FS1807-59322009000800016&amp;rft.au=Jiin-Yu+Chen&amp;rft.au=Michelle+Scerbo&amp;rft.au=George+Kramer&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2728196&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NatansonJAMA2008-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NatansonJAMA2008_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (May 2008). \"Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis\". <i>JAMA</i>. <b>299</b> (19): 2304\u201312. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.299.19.jrv80007\">10.1001/jama.299.19.jrv80007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18443023\">18443023</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Cell-free+hemoglobin-based+blood+substitutes+and+risk+of+myocardial+infarction+and+death%3A+a+meta-analysis&amp;rft.volume=299&amp;rft.issue=19&amp;rft.pages=2304-12&amp;rft.date=2008-05&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.299.19.jrv80007&amp;rft_id=info%3Apmid%2F18443023&amp;rft.aulast=Natanson&amp;rft.aufirst=C&amp;rft.au=Kern%2C+SJ&amp;rft.au=Lurie%2C+P&amp;rft.au=Banks%2C+SM&amp;rft.au=Wolfe%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sloan, EP; Koenigsberg, M; Weir, WB; Clark, JM; O'Connor, R; Olinger, M; Cydulka, R (February 2015). \"Emergency Resuscitation of Patients Enrolled in the US Diaspirin Cross-linked Hemoglobin (DCLHb) Clinical Efficacy Trial\". <i>Prehospital and disaster medicine</i>. <b>30</b> (1): 54\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1017/S1049023X14001174\">10.1017/S1049023X14001174</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25499006\">25499006</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prehospital+and+disaster+medicine&amp;rft.atitle=Emergency+Resuscitation+of+Patients+Enrolled+in+the+US+Diaspirin+Cross-linked+Hemoglobin+%28DCLHb%29+Clinical+Efficacy+Trial.&amp;rft.volume=30&amp;rft.issue=1&amp;rft.pages=54-61&amp;rft.date=2015-02&amp;rft_id=info%3Adoi%2F10.1017%2FS1049023X14001174&amp;rft_id=info%3Apmid%2F25499006&amp;rft.aulast=Sloan&amp;rft.aufirst=EP&amp;rft.au=Koenigsberg%2C+M&amp;rft.au=Weir%2C+WB&amp;rft.au=Clark%2C+JM&amp;rft.au=O%27Connor%2C+R&amp;rft.au=Olinger%2C+M&amp;rft.au=Cydulka%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Zehr, Leonard (June 21, 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theglobeandmail.com/report-on-business/tests-leave-hemosol-in-critical-condition/article1162984/\">\"Tests leave Hemosol in critical condition\"</a>. <i>Globe and Mail</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Globe+and+Mail&amp;rft.atitle=Tests+leave+Hemosol+in+critical+condition&amp;rft.date=2003-06-21&amp;rft.aulast=Zehr&amp;rft.aufirst=Leonard&amp;rft_id=https%3A%2F%2Fwww.theglobeandmail.com%2Freport-on-business%2Ftests-leave-hemosol-in-critical-condition%2Farticle1162984%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cbc.ca/news/business/hemosol-declares-insolvency-shares-under-review-by-tsx-1.550185\">\"Hemosol declares insolvency; shares under review by TSX\"</a>. <i>CBC News</i>. November 25, 2005.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBC+News&amp;rft.atitle=Hemosol+declares+insolvency%3B+shares+under+review+by+TSX&amp;rft.date=2005-11-25&amp;rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fbusiness%2Fhemosol-declares-insolvency-shares-under-review-by-tsx-1.550185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www2.prnewswire.com/gh/cnoc/comp/131224.html\">Biopure files for relief</a><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since August 2018\">permanent dead link</span></a></i>&#93;</span></sup> PR Newswire, July 16, 2009.</span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercebiotech.com/biotech/fda-rejects-northfield-s-blood-substitute\">\"FDA rejects Northfield's blood substitute\"</a>. <i>FierceBiotech</i>. May 1, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FierceBiotech&amp;rft.atitle=FDA+rejects+Northfield%27s+blood+substitute&amp;rft.date=2009-05-01&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Ffda-rejects-northfield-s-blood-substitute&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/northfieldlaboratories/northfield-laboratories-to-liquidate-under-chapter-11-idUSBNG20947820090602\">\"Northfield Laboratories to liquidate under Chapter 11\"</a>. <i>Reuters</i>. 2 June 2009<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-12-31</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Northfield+Laboratories+to+liquidate+under+Chapter+11&amp;rft.date=2009-06-02&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fnorthfieldlaboratories%2Fnorthfield-laboratories-to-liquidate-under-chapter-11-idUSBNG20947820090602&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vincent, JL; Privalle, CT; Singer, M; Lorente, JA; Boehm, E; Meier-Hellmann, A; Darius, H; Ferrer, R; Sirvent, JM; Marx, G; DeAngelo, J (January 2015). \"Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)\". <i>Critical care medicine</i>. <b>43</b> (1): 57\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/CCM.0000000000000554\">10.1097/CCM.0000000000000554</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25083980\">25083980</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+care+medicine&amp;rft.atitle=Multicenter%2C+randomized%2C+placebo-controlled+phase+III+study+of+pyridoxalated+hemoglobin+polyoxyethylene+in+distributive+shock+%28PHOENIX%29.&amp;rft.volume=43&amp;rft.issue=1&amp;rft.pages=57-64&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1097%2FCCM.0000000000000554&amp;rft_id=info%3Apmid%2F25083980&amp;rft.aulast=Vincent&amp;rft.aufirst=JL&amp;rft.au=Privalle%2C+CT&amp;rft.au=Singer%2C+M&amp;rft.au=Lorente%2C+JA&amp;rft.au=Boehm%2C+E&amp;rft.au=Meier-Hellmann%2C+A&amp;rft.au=Darius%2C+H&amp;rft.au=Ferrer%2C+R&amp;rft.au=Sirvent%2C+JM&amp;rft.au=Marx%2C+G&amp;rft.au=DeAngelo%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.curacyte.eu/\">\"Curacyte\"</a>. Curacyte<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">30 December</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Curacyte&amp;rft.pub=Curacyte&amp;rft_id=http%3A%2F%2Fwww.curacyte.eu%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rousseau GF, Giarratana MC, Douay L (Jan 2014). \"Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?\". <i>Biotechnol. J</i>. <b>9</b> (1): 28\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/biot.201200368\">10.1002/biot.201200368</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biotechnol.+J.&amp;rft.atitle=Large-scale+production+of+red+blood+cells+from+stem+cells%3A+what+are+the+technical+challenges+ahead%3F&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=28-38&amp;rft.date=2014-01&amp;rft_id=info%3Adoi%2F10.1002%2Fbiot.201200368&amp;rft.aulast=Rousseau&amp;rft.aufirst=GF&amp;rft.au=Giarratana%2C+MC&amp;rft.au=Douay%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABlood+substitute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Edwards-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Edwards_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Edwards_34-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Edwards, L. (July 13, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.physorg.com/news198221258.html\">Artificial blood developed for the battlefield</a>. Retrieved November 30, 2010</span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Blood_substitute&amp;action=edit&amp;section=8\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://science.howstuffworks.com/innovation/everyday-innovations/artificial-blood3.htm\">\"How Artificial Blood Works\"</a> at <a href=\"/wiki/HowStuffWorks\" title=\"HowStuffWorks\">HowStuffWorks</a></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Transfusion_medicine\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Transfusion_medicine\" title=\"Template:Transfusion medicine\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Transfusion_medicine\" title=\"Template talk:Transfusion medicine\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Transfusion_medicine&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Transfusion_medicine\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Transfusion_medicine\" title=\"Transfusion medicine\">Transfusion medicine</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">General concepts</th><td class=\"navbox-list navbox-odd hlist mn cv vcxxsd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Apheresis\" title=\"Apheresis\">Apheresis</a>  (<a href=\"/wiki/Plasmapheresis\" title=\"Plasmapheresis\">plasmapheresis</a>, <a href=\"/wiki/Plateletpheresis\" title=\"Plateletpheresis\">plateletpheresis</a>, <a href=\"/wiki/Leukapheresis\" title=\"Leukapheresis\">leukapheresis</a>)</li>\n<li><a href=\"/wiki/Blood_transfusion\" title=\"Blood transfusion\">Blood transfusion</a></li>\n<li><a href=\"/wiki/Coombs_test\" title=\"Coombs test\">Coombs test</a> (direct and indirect)</li>\n<li><a href=\"/wiki/Cross-matching\" title=\"Cross-matching\">Cross-matching</a></li>\n<li><a href=\"/wiki/Exchange_transfusion\" title=\"Exchange transfusion\">Exchange transfusion</a></li>\n<li><a href=\"/wiki/International_Society_of_Blood_Transfusion\" title=\"International Society of Blood Transfusion\">International Society of Blood Transfusion</a></li>\n<li><a href=\"/wiki/Intraoperative_blood_salvage\" title=\"Intraoperative blood salvage\">Intraoperative blood salvage</a></li>\n<li><a href=\"/wiki/ISBT_128\" title=\"ISBT 128\">ISBT 128</a></li>\n<li><a href=\"/wiki/Blood_transfusion#Adverse_effects\" title=\"Blood transfusion\">Transfusion reactions</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Human_blood_group_systems\" title=\"Human blood group systems\">Blood group systems</a>&#160;/<br /><a href=\"/wiki/Blood_type\" title=\"Blood type\">blood types</a></th><td class=\"navbox-list navbox-even hlist mn cv vcxxsd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/ABO_blood_group_system\" title=\"ABO blood group system\">ABO</a></li>\n<li><a href=\"/wiki/Complement_component_4\" title=\"Complement component 4\">Chido-Rodgers</a></li>\n<li><a href=\"/wiki/Colton_antigen_system\" title=\"Colton antigen system\">Colton</a></li>\n<li><a href=\"/wiki/Decay-accelerating_factor\" title=\"Decay-accelerating factor\">Cromer</a></li>\n<li><a href=\"/wiki/Diego_antigen_system\" title=\"Diego antigen system\">Diego</a></li>\n<li><a href=\"/wiki/ART4\" title=\"ART4\">Dombrock</a></li>\n<li><a href=\"/wiki/Duffy_antigen_system\" title=\"Duffy antigen system\">Duffy</a></li>\n<li><a href=\"/w/index.php?title=Er_blood_group_collection&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Er blood group collection (page does not exist)\">Er</a></li>\n<li><a href=\"/w/index.php?title=Forssman_antigen_system&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Forssman antigen system (page does not exist)\">FORS</a></li>\n<li><a href=\"/wiki/Glycophorin_C\" title=\"Glycophorin C\">Gerbich</a></li>\n<li><a href=\"/wiki/Aquaporin_3\" title=\"Aquaporin 3\">GIL</a></li>\n<li><a href=\"/wiki/Globoside\" title=\"Globoside\">GLOB</a></li>\n<li><a href=\"/wiki/Hh_blood_group\" title=\"Hh blood group\">Hh</a></li>\n<li><a href=\"/wiki/Ii_antigen_system\" title=\"Ii antigen system\">Ii</a></li>\n<li><a href=\"/wiki/Indian_blood_group_system\" title=\"Indian blood group system\">Indian</a></li>\n<li><a href=\"/w/index.php?title=Junior_blood_group_system&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Junior blood group system (page does not exist)\">JR</a></li>\n<li><a href=\"/wiki/SEMA7A\" title=\"SEMA7A\">JMH</a></li>\n<li><a href=\"/wiki/Kell_antigen_system\" title=\"Kell antigen system\">Kell</a> (<a href=\"/wiki/XK_(protein)\" title=\"XK (protein)\">Xk</a>)</li>\n<li><a href=\"/wiki/Kidd_antigen_system\" title=\"Kidd antigen system\">Kidd</a></li>\n<li><a href=\"/wiki/Complement_receptor_1\" title=\"Complement receptor 1\">Knops</a></li>\n<li><a href=\"/w/index.php?title=Lan_blood_group_system&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Lan blood group system (page does not exist)\">Lan</a></li>\n<li><a href=\"/wiki/Lewis_antigen_system\" title=\"Lewis antigen system\">Lewis</a></li>\n<li><a href=\"/wiki/Lutheran_antigen_system\" title=\"Lutheran antigen system\">Lutheran</a></li>\n<li><a href=\"/wiki/ICAM4\" title=\"ICAM4\">LW</a></li>\n<li><a href=\"/wiki/MNS_antigen_system\" title=\"MNS antigen system\">MNS</a></li>\n<li><a href=\"/wiki/Basigin\" title=\"Basigin\">OK</a></li>\n<li><a href=\"/wiki/P_antigen_system\" title=\"P antigen system\">P</a></li>\n<li><a href=\"/wiki/CD151\" title=\"CD151\">Raph</a></li>\n<li><a href=\"/wiki/Rh_blood_group_system\" title=\"Rh blood group system\">Rh</a> and <a href=\"/wiki/RHAG\" title=\"RHAG\">RHAG</a></li>\n<li><a href=\"/wiki/ERMAP\" title=\"ERMAP\">Scianna</a></li>\n<li><a href=\"/wiki/C1GALT1\" title=\"C1GALT1\">T-Tn</a></li>\n<li><a href=\"/w/index.php?title=Vel_blood_group&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Vel blood group (page does not exist)\">Vel</a></li>\n<li><a href=\"/wiki/Xg_antigen_system\" title=\"Xg antigen system\">Xg</a></li>\n<li><a href=\"/wiki/Yt_antigen_system\" title=\"Yt antigen system\">Yt</a></li>\n<li><a href=\"/wiki/Human_red_cell_antigens\" title=\"Human red cell antigens\">Other</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Blood_product\" title=\"Blood product\">Blood products</a>&#160;/<br /><a href=\"/wiki/Blood_donation\" title=\"Blood donation\">blood donation</a></th><td class=\"navbox-list navbox-odd hlist mn cv vcxxsd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Whole_blood\" title=\"Whole blood\">Whole blood</a></li>\n<li><a href=\"/wiki/Platelet\" title=\"Platelet\">Platelets</a></li>\n<li><a href=\"/wiki/Packed_red_blood_cells\" title=\"Packed red blood cells\">Red blood cells</a></li>\n<li><a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">Plasma</a>&#160;/ <a href=\"/wiki/Fresh_frozen_plasma\" title=\"Fresh frozen plasma\">Fresh frozen plasma</a>&#160;/ <a href=\"/wiki/Plasma_frozen_within_24_hours\" title=\"Plasma frozen within 24 hours\">PF24</a> (<a href=\"/wiki/Cryoprecipitate\" title=\"Cryoprecipitate\">Cryoprecipitate</a> + <a href=\"/wiki/Cryosupernatant\" title=\"Cryosupernatant\">Cryosupernatant</a>)</li>\n<li><a class=\"mw-selflink selflink\">Blood substitutes</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Intravenous_therapy\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Intravenous_therapy\" title=\"Template:Intravenous therapy\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Intravenous_therapy\" title=\"Template talk:Intravenous therapy\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Intravenous_therapy&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Intravenous_therapy\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Intravenous_therapy\" title=\"Intravenous therapy\">Intravenous therapy</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Infused substances</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Blood_product\" title=\"Blood product\">Blood-based product</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Whole_blood\" title=\"Whole blood\">Whole blood</a></li>\n<li><a href=\"/wiki/Plasma_frozen_within_24_hours_after_phlebotomy\" class=\"mw-redirect\" title=\"Plasma frozen within 24 hours after phlebotomy\">PF24</a>/<a href=\"/wiki/Fresh_frozen_plasma\" title=\"Fresh frozen plasma\">Fresh frozen plasma</a> (<a href=\"/wiki/Cryosupernatant\" title=\"Cryosupernatant\">Cryosupernatant</a> + <a href=\"/wiki/Cryoprecipitate\" title=\"Cryoprecipitate\">Cryoprecipitate</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a class=\"mw-selflink selflink\">Blood substitute</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Hemoglobin-based_oxygen_carriers\" class=\"mw-redirect\" title=\"Hemoglobin-based oxygen carriers\">Hemoglobin-based</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Volume_expander\" title=\"Volume expander\">Volume expander</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Lactated_Ringer%27s_solution\" class=\"mw-redirect\" title=\"Lactated Ringer&#39;s solution\">Lactated Ringer's</a></li>\n<li><a href=\"/wiki/Saline_(medicine)\" title=\"Saline (medicine)\">Normal saline</a></li>\n<li><a href=\"/wiki/Intravenous_sugar_solution\" title=\"Intravenous sugar solution\">Sugar solution</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Intravenous_therapy#Buffer_solutions\" title=\"Intravenous therapy\">Buffers</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Lactated_Ringer%27s_solution\" class=\"mw-redirect\" title=\"Lactated Ringer&#39;s solution\">Lactated Ringer's</a>, <a href=\"/wiki/Intravenous_sodium_bicarbonate\" title=\"Intravenous sodium bicarbonate\">Sodium bicarbonate</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Medications</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Intravenous_immunoglobulin\" class=\"mw-redirect\" title=\"Intravenous immunoglobulin\">Intravenous immunoglobulin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Parenteral_nutrition\" title=\"Parenteral nutrition\">Parenteral nutrition</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Intravenous_sugar_solution\" title=\"Intravenous sugar solution\">Sugar</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Drug_injection\" title=\"Drug injection\">Drug injection</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Access points</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Peripheral_venous_catheter\" title=\"Peripheral venous catheter\">Peripheral venous catheter</a></li>\n<li><a href=\"/wiki/Peripherally_inserted_central_catheter\" title=\"Peripherally inserted central catheter\">Peripherally inserted central catheter</a> (<a href=\"/wiki/Seldinger_technique\" title=\"Seldinger technique\">Seldinger technique</a>)</li>\n<li><a href=\"/wiki/Central_venous_catheter\" title=\"Central venous catheter\">Central venous catheter</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other equipment</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Infusion_pump\" title=\"Infusion pump\">Infusion pump</a></li>\n<li><a href=\"/wiki/Central_venous_catheter\" title=\"Central venous catheter\">CVC</a>\n<ul><li><a href=\"/w/index.php?title=Single-lumen_catheter&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Single-lumen catheter (page does not exist)\">SLC</a></li>\n<li><a href=\"/w/index.php?title=Multiple-lumen_catheter&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Multiple-lumen catheter (page does not exist)\">MLC</a></li>\n<li><a href=\"/wiki/Peripherally_inserted_central_catheter\" title=\"Peripherally inserted central catheter\">PICC</a></li>\n<li><a href=\"/w/index.php?title=Implantable_catheter&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Implantable catheter (page does not exist)\">Implantable catheters</a></li>\n<li><a href=\"/wiki/Port_(medical)\" title=\"Port (medical)\">Ports</a></li>\n<li><a href=\"/w/index.php?title=Thermodilution_catheters&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Thermodilution catheters (page does not exist)\">Thermodilution catheters</a></li>\n<li><a href=\"/wiki/Hemodialysis_catheters\" class=\"mw-redirect\" title=\"Hemodialysis catheters\">Hemodialysis catheters</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Specific risks</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Air_embolism\" title=\"Air embolism\">Air embolism</a></li>\n<li><a href=\"/wiki/Extravasation_(intravenous)\" title=\"Extravasation (intravenous)\">Extravasation</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1317\nCached time: 20180905102104\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.452 seconds\nReal time usage: 0.531 seconds\nPreprocessor visited node count: 2490/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 108935/2097152 bytes\nTemplate argument size: 2583/2097152 bytes\nHighest expansion depth: 14/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 46337/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.220/10.000 seconds\nLua memory usage: 4.92 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  436.897      1 -total\n 59.74%  260.982      1 Template:Reflist\n 34.01%  148.587     23 Template:Cite_journal\n  9.80%   42.823      1 Template:Refimprove_section\n  8.53%   37.247      1 Template:Refimprove\n  7.88%   34.436      4 Template:Fix\n  7.19%   31.397      1 Template:Ambox\n  7.02%   30.654      2 Template:Citation_needed\n  6.67%   29.126      1 Template:For\n  5.04%   22.002      3 Template:Navbox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:415016-0!canonical and timestamp 20180905102104 and revision id 858141294\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A8%D8%AF%D9%8A%D9%84_%D8%A7%D9%84%D8%AF%D9%85","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0628\u062f\u064a\u0644 \u0627\u0644\u062f\u0645"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Krevn%C3%AD_n%C3%A1hra%C5%BEka","langname":"Czech","autonym":"\u010de\u0161tina","*":"Krevn\u00ed n\u00e1hra\u017eka"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Blutersatz","langname":"German","autonym":"Deutsch","*":"Blutersatz"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Substitut_sanguin","langname":"French","autonym":"fran\u00e7ais","*":"Substitut sanguin"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EB%8C%80%EC%B2%B4_%ED%98%88%EC%95%A1","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ub300\uccb4 \ud608\uc561"},{"lang":"hi","url":"https://hi.wikipedia.org/wiki/%E0%A4%95%E0%A5%83%E0%A4%A4%E0%A5%8D%E0%A4%B0%E0%A4%BF%E0%A4%AE_%E0%A4%B0%E0%A4%95%E0%A5%8D%E0%A4%A4","langname":"Hindi","autonym":"\u0939\u093f\u0928\u094d\u0926\u0940","*":"\u0915\u0943\u0924\u094d\u0930\u093f\u092e \u0930\u0915\u094d\u0924"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Surrogati_del_sangue","langname":"Italian","autonym":"italiano","*":"Surrogati del sangue"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E4%BB%A3%E6%9B%BF%E8%A1%80%E6%B6%B2","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u4ee3\u66ff\u8840\u6db2"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Alternativas_m%C3%A9dicas_ao_sangue","langname":"Portuguese","autonym":"portugu\u00eas","*":"Alternativas m\u00e9dicas ao sangue"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9A%D1%80%D0%BE%D0%B2%D0%B5%D0%B7%D0%B0%D0%BC%D0%B5%D0%BD%D0%B8%D1%82%D0%B5%D0%BB%D1%8C","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041a\u0440\u043e\u0432\u0435\u0437\u0430\u043c\u0435\u043d\u0438\u0442\u0435\u043b\u044c"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Blood_substitute","langname":"Simple English","autonym":"Simple English","*":"Blood substitute"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E4%BA%BA%E5%B7%A5%E8%A1%80","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u4eba\u5de5\u8840"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_April_2017"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_August_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"Blood Substitutes","hidden":"","*":"Articles_needing_additional_references_from_February_2014"},{"sortkey":"Blood Substitutes","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"Blood Substitutes","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Blood Substitutes","hidden":"","*":"Articles_with_unsourced_statements_from_December_2017"},{"sortkey":" ","*":"Blood_substitutes"},{"sortkey":"Blood Substitutes","*":"Synthetic_biology"}],"links":[{"ns":14,"exists":"","*":"Category:Articles needing additional references from February 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from December 2017"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from April 2017"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from August 2018"},{"ns":10,"exists":"","*":"Template:Transfusion medicine"},{"ns":10,"exists":"","*":"Template:Intravenous therapy"},{"ns":0,"exists":"","*":"ABO blood group system"},{"ns":0,"exists":"","*":"ART4"},{"ns":0,"exists":"","*":"Air embolism"},{"ns":0,"exists":"","*":"Albumin"},{"ns":0,"exists":"","*":"Antibiotics"},{"ns":0,"exists":"","*":"Apheresis"},{"ns":0,"exists":"","*":"Aquaporin 3"},{"ns":0,"exists":"","*":"Artificial Cells, Blood Substitutes, and Biotechnology"},{"ns":0,"exists":"","*":"Basigin"},{"ns":0,"exists":"","*":"Baxter Healthcare"},{"ns":0,"exists":"","*":"Biologic License Application"},{"ns":0,"exists":"","*":"Biological tissue"},{"ns":0,"exists":"","*":"Biology"},{"ns":0,"exists":"","*":"Biopure"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Blood-based product"},{"ns":0,"exists":"","*":"Blood donation"},{"ns":0,"exists":"","*":"Blood plasma"},{"ns":0,"exists":"","*":"Blood plasma substitute (disambiguation)"},{"ns":0,"exists":"","*":"Blood product"},{"ns":0,"exists":"","*":"Blood replacement"},{"ns":0,"exists":"","*":"Blood transfusion"},{"ns":0,"exists":"","*":"Blood type"},{"ns":0,"exists":"","*":"Blood types"},{"ns":0,"exists":"","*":"Bloodless surgery"},{"ns":0,"exists":"","*":"Br. Med. Bull."},{"ns":0,"exists":"","*":"C1GALT1"},{"ns":0,"exists":"","*":"CD151"},{"ns":0,"exists":"","*":"Capillaries"},{"ns":0,"exists":"","*":"Central venous catheter"},{"ns":0,"exists":"","*":"Colton antigen system"},{"ns":0,"exists":"","*":"Complement component 4"},{"ns":0,"exists":"","*":"Complement receptor 1"},{"ns":0,"exists":"","*":"Contaminated haemophilia blood products"},{"ns":0,"exists":"","*":"Coombs test"},{"ns":0,"exists":"","*":"Cross-link"},{"ns":0,"exists":"","*":"Cross-matching"},{"ns":0,"exists":"","*":"Cryoprecipitate"},{"ns":0,"exists":"","*":"Cryosupernatant"},{"ns":0,"exists":"","*":"Decay-accelerating factor"},{"ns":0,"exists":"","*":"Defense Advanced Research Projects Agency"},{"ns":0,"exists":"","*":"Diego antigen system"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug injection"},{"ns":0,"exists":"","*":"Duffy antigen system"},{"ns":0,"exists":"","*":"ERMAP"},{"ns":0,"exists":"","*":"Emulsion"},{"ns":0,"exists":"","*":"Erythromer"},{"ns":0,"exists":"","*":"Europe"},{"ns":0,"exists":"","*":"Exchange transfusion"},{"ns":0,"exists":"","*":"Extravasation (intravenous)"},{"ns":0,"exists":"","*":"Fluosol"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Fresh frozen plasma"},{"ns":0,"exists":"","*":"Genetically engineered"},{"ns":0,"exists":"","*":"Globoside"},{"ns":0,"exists":"","*":"Glycophorin C"},{"ns":0,"exists":"","*":"Green Cross (Japan)"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"Haemoglobin"},{"ns":0,"exists":"","*":"Hematopoietic"},{"ns":0,"exists":"","*":"Hematopoietic stem cell"},{"ns":0,"exists":"","*":"Hemodialysis catheters"},{"ns":0,"exists":"","*":"Hemoglobin-based oxygen carriers"},{"ns":0,"exists":"","*":"Hh blood group"},{"ns":0,"exists":"","*":"HowStuffWorks"},{"ns":0,"exists":"","*":"Human"},{"ns":0,"exists":"","*":"Human blood group systems"},{"ns":0,"exists":"","*":"Human red cell antigens"},{"ns":0,"exists":"","*":"Hyperbaric chamber"},{"ns":0,"exists":"","*":"ICAM4"},{"ns":0,"exists":"","*":"ISBT 128"},{"ns":0,"exists":"","*":"Ii antigen system"},{"ns":0,"exists":"","*":"Indian blood group system"},{"ns":0,"exists":"","*":"Induced stem cells"},{"ns":0,"exists":"","*":"Infusion pump"},{"ns":0,"exists":"","*":"International Society of Blood Transfusion"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Intraoperative blood salvage"},{"ns":0,"exists":"","*":"Intravenous immunoglobulin"},{"ns":0,"exists":"","*":"Intravenous sodium bicarbonate"},{"ns":0,"exists":"","*":"Intravenous sugar solution"},{"ns":0,"exists":"","*":"Intravenous therapy"},{"ns":0,"exists":"","*":"Japan"},{"ns":0,"exists":"","*":"Jehovah's Witnesses"},{"ns":0,"exists":"","*":"Kell antigen system"},{"ns":0,"exists":"","*":"Kidd antigen system"},{"ns":0,"exists":"","*":"Lactated Ringer's solution"},{"ns":0,"exists":"","*":"Lecithin"},{"ns":0,"exists":"","*":"Leukapheresis"},{"ns":0,"exists":"","*":"Lewis antigen system"},{"ns":0,"exists":"","*":"Liquid breathing"},{"ns":0,"exists":"","*":"Lutheran antigen system"},{"ns":0,"exists":"","*":"MNS antigen system"},{"ns":0,"exists":"","*":"Mad cow disease"},{"ns":0,"exists":"","*":"Mammal"},{"ns":0,"exists":"","*":"N. Engl. J. Med."},{"ns":0,"exists":"","*":"Northfield Laboratories"},{"ns":0,"exists":"","*":"Nutrient"},{"ns":0,"exists":"","*":"Oxycyte"},{"ns":0,"exists":"","*":"Oxygen"},{"ns":0,"exists":"","*":"Oxygen therapeutic"},{"ns":0,"exists":"","*":"PEGylation"},{"ns":0,"exists":"","*":"P antigen system"},{"ns":0,"exists":"","*":"Packed red blood cells"},{"ns":0,"exists":"","*":"Parenteral nutrition"},{"ns":0,"exists":"","*":"Perfluorocarbon"},{"ns":0,"exists":"","*":"Perfluorocarbons"},{"ns":0,"exists":"","*":"Perfluorodecalin"},{"ns":0,"exists":"","*":"Perfluorotributylamine"},{"ns":0,"exists":"","*":"Peripheral venous catheter"},{"ns":0,"exists":"","*":"Peripherally inserted central catheter"},{"ns":0,"exists":"","*":"Plasma frozen within 24 hours"},{"ns":0,"exists":"","*":"Plasma frozen within 24 hours after phlebotomy"},{"ns":0,"exists":"","*":"Plasmapheresis"},{"ns":0,"exists":"","*":"Platelet"},{"ns":0,"exists":"","*":"Plateletpheresis"},{"ns":0,"exists":"","*":"Polymerization"},{"ns":0,"exists":"","*":"Polyoxyethylene"},{"ns":0,"exists":"","*":"Port (medical)"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"RHAG"},{"ns":0,"exists":"","*":"Red blood cell"},{"ns":0,"exists":"","*":"Rh blood group system"},{"ns":0,"exists":"","*":"SEMA7A"},{"ns":0,"exists":"","*":"Saline (medicine)"},{"ns":0,"exists":"","*":"Salt (chemistry)"},{"ns":0,"exists":"","*":"Science (journal)"},{"ns":0,"exists":"","*":"Seldinger technique"},{"ns":0,"exists":"","*":"Sir Christopher Wren"},{"ns":0,"exists":"","*":"South Africa"},{"ns":0,"exists":"","*":"Stem cell"},{"ns":0,"exists":"","*":"Surfactant"},{"ns":0,"exists":"","*":"Theatrical blood"},{"ns":0,"exists":"","*":"Transfusion (journal)"},{"ns":0,"exists":"","*":"Transfusion medicine"},{"ns":0,"exists":"","*":"Traumatic brain injury"},{"ns":0,"exists":"","*":"Umbilical cord"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"United States Department of Defense"},{"ns":0,"exists":"","*":"Vitamin"},{"ns":0,"exists":"","*":"Volume expander"},{"ns":0,"exists":"","*":"Water"},{"ns":0,"exists":"","*":"Water soluble"},{"ns":0,"exists":"","*":"Whole blood"},{"ns":0,"exists":"","*":"William Harvey"},{"ns":0,"exists":"","*":"XK (protein)"},{"ns":0,"exists":"","*":"Xg antigen system"},{"ns":0,"exists":"","*":"Yt antigen system"},{"ns":0,"*":"Er blood group collection"},{"ns":0,"*":"Forssman antigen system"},{"ns":0,"*":"Junior blood group system"},{"ns":0,"*":"Lan blood group system"},{"ns":0,"*":"Vel blood group"},{"ns":0,"*":"Single-lumen catheter"},{"ns":0,"*":"Multiple-lumen catheter"},{"ns":0,"*":"Implantable catheter"},{"ns":0,"*":"Thermodilution catheters"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Intravenous therapy"},{"ns":11,"exists":"","*":"Template talk:Transfusion medicine"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:For"},{"ns":10,"exists":"","*":"Template:Refimprove section"},{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Sfrac"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Chem"},{"ns":10,"exists":"","*":"Template:Chem/link"},{"ns":10,"exists":"","*":"Template:Chem/atom"},{"ns":10,"exists":"","*":"Template:Su"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Transfusion medicine"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Intravenous therapy"},{"ns":828,"exists":"","*":"Module:For"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Su"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Lock-green.svg","Question_book-new.svg"],"externallinks":["https://web.archive.org/web/20160304185434/http://www.aana.com/newsandjournal/Documents/henkelhanke205-211.pdf","//www.ncbi.nlm.nih.gov/pubmed/17591302","http://www.aana.com/newsandjournal/Documents/henkelhanke205-211.pdf","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2738310","//doi.org/10.4103/0972-5229.43685","//www.ncbi.nlm.nih.gov/pubmed/19742251","http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=11834811","//doi.org/10.1126/science.1068443","//www.ncbi.nlm.nih.gov/pubmed/11834811","//doi.org/10.1111/tme.12075","//www.ncbi.nlm.nih.gov/pubmed/24003949","//doi.org/10.1152/physrev.1983.63.1.1","//www.ncbi.nlm.nih.gov/pubmed/6296890","//doi.org/10.1152/jappl.2000.88.4.1467","//www.ncbi.nlm.nih.gov/pubmed/10749843","//doi.org/10.1046/j.1537-2995.2003.00314.x","//www.ncbi.nlm.nih.gov/pubmed/12559026","//doi.org/10.1056/NEJM199902113400606","//www.ncbi.nlm.nih.gov/pubmed/9971869","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5372714","//doi.org/10.3390/biom7010002","//www.ncbi.nlm.nih.gov/pubmed/28054978","http://bmb.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10695091","//doi.org/10.1258/0007142991902259","//www.ncbi.nlm.nih.gov/pubmed/10695091","//doi.org/10.1002/0471266949.bmc048.pub2","http://circ.ahajournals.org/content/90/1/114.abstract","//doi.org/10.1161/01.CIR.90.1.114","//www.ncbi.nlm.nih.gov/pubmed/8025985","http://www.thefreelibrary.com/Oxycyte+is+on+track+as+oxygen+carrier,+not+as+'faux'+blood-a0204011942","https://clinicaltrials.gov/ct2/show/NCT00908063","//www.ncbi.nlm.nih.gov/pubmed/15768564","https://clinicaltrials.gov/ct2/show/NCT02189109","//doi.org/10.1007/s11094-009-0268-1","//www.worldcat.org/issn/0091-150X","//doi.org/10.1016/j.ccc.2008.12.007","http://www.nature.com/nbt/journal/v20/n10/full/nbt1002-962.html","//doi.org/10.1038/nbt1002-962","//www.worldcat.org/issn/1087-0156","http://jap.physiology.org/content/1/7/469.long","//www.ncbi.nlm.nih.gov/pubmed/18104040","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2728196","//doi.org/10.1590/S1807-59322009000800016","//www.ncbi.nlm.nih.gov/pubmed/19690667","//doi.org/10.1001/jama.299.19.jrv80007","//www.ncbi.nlm.nih.gov/pubmed/18443023","//doi.org/10.1017/S1049023X14001174","//www.ncbi.nlm.nih.gov/pubmed/25499006","https://www.theglobeandmail.com/report-on-business/tests-leave-hemosol-in-critical-condition/article1162984/","http://www.cbc.ca/news/business/hemosol-declares-insolvency-shares-under-review-by-tsx-1.550185","http://www2.prnewswire.com/gh/cnoc/comp/131224.html","https://www.fiercebiotech.com/biotech/fda-rejects-northfield-s-blood-substitute","https://www.reuters.com/article/northfieldlaboratories/northfield-laboratories-to-liquidate-under-chapter-11-idUSBNG20947820090602","//doi.org/10.1097/CCM.0000000000000554","//www.ncbi.nlm.nih.gov/pubmed/25083980","http://www.curacyte.eu/","//doi.org/10.1002/biot.201200368","http://www.physorg.com/news198221258.html","https://science.howstuffworks.com/innovation/everyday-innovations/artificial-blood3.htm"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Blood_substitute","byteoffset":1780,"anchor":"History"},{"toclevel":1,"level":"2","line":"Approaches","number":"2","index":"2","fromtitle":"Blood_substitute","byteoffset":6166,"anchor":"Approaches"},{"toclevel":2,"level":"3","line":"Perfluorocarbon based","number":"2.1","index":"3","fromtitle":"Blood_substitute","byteoffset":7316,"anchor":"Perfluorocarbon_based"},{"toclevel":2,"level":"3","line":"Haemoglobin based","number":"2.2","index":"4","fromtitle":"Blood_substitute","byteoffset":14454,"anchor":"Haemoglobin_based"},{"toclevel":2,"level":"3","line":"Stem cells","number":"2.3","index":"5","fromtitle":"Blood_substitute","byteoffset":21290,"anchor":"Stem_cells"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"6","fromtitle":"Blood_substitute","byteoffset":23274,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"7","fromtitle":"Blood_substitute","byteoffset":23558,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"8","fromtitle":"Blood_substitute","byteoffset":23591,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Blood substitute","iwlinks":[],"properties":[{"name":"defaultsort","*":"Blood Substitutes"},{"name":"wikibase_item","*":"Q831050"}]}}